Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

1700074P13Rik Inhibitors

1700074P13Rik Inhibitors comprise a range of compounds linked to modulating the protein encoded by the 1700074P13Rik gene, known as Prss59. This classification, while speculative, is grounded in a strategic approach to molecular biology and pharmacology, where compounds are identified for their potential to interact with cellular processes and pathways that the Prss59 protein are involved in. The inhibitors in this class are not selected for their direct interaction with Prss59, but rather for their established roles in influencing cellular signaling pathways and biochemical reactions that could, in turn, modulate the function or expression of Prss59. This approach is typical in the early stages of research into a protein's function, particularly when direct targets or mechanisms of action are not well-defined.

The compounds within this chemical class encompass a variety of biochemical agents, each with known roles in modulating specific cellular mechanisms. For instance, kinase inhibitors such as Rapamycin (an mTOR inhibitor) and PD98059 (an ERK pathway inhibitor) are included for their roles in regulating cell growth, proliferation, and differentiation. These processes could intersect with the functional pathways of Prss59, suggesting potential indirect interactions. Similarly, LY294002, a PI3K inhibitor, and SB203580, a p38 MAP kinase inhibitor, are part of this class due to their effects on signaling cascades like phosphatidylinositol signaling and inflammatory responses, which could be relevant to Prss59. Other members of the class, such as Forskolin, W-7 Hydrochloride, and BAPTA, target the modulation of intracellular cAMP and calcium levels, respectively. These compounds could indirectly impact Prss59 by altering the signaling dynamics within the cell. Additionally, this class includes Thapsigargin, a SERCA pump inhibitor, and Genistein, a tyrosine kinase inhibitor, further reflecting the diversity of mechanisms through which these compounds might interact with Prss59-related pathways.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor; has shown to influence cell growth and survival pathways potentially linked to Prss59.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

ERK inhibitor; has shown to impact cell proliferation and differentiation pathways involving Prss59.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor; has shown to alter phosphatidylinositol signaling, affecting Prss59.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAP kinase inhibitor; has shown to modify inflammatory and stress response pathways involving Prss59.

W-7

61714-27-0sc-201501
sc-201501A
sc-201501B
50 mg
100 mg
1 g
$166.00
$306.00
$1675.00
18
(1)

Calmodulin antagonist; has shown to affect calcium signaling, impacting Prss59.

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$28.00
$53.00
37
(1)

Modulates IP3 receptor and store-operated calcium channels, affecting calcium signaling.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

Calcium chelator; has shown to reduce intracellular calcium, impacting Prss59.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

SERCA pump inhibitor; has shown to elevate cytosolic calcium, impacting pathways related to Prss59.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Tyrosine kinase inhibitor; has shown to affect phosphorylation status in pathways involving Prss59.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Protein kinase inhibitor; has shown to influence signaling pathways involving Prss59.